Clinical Trial Update: NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating neoadjuvant abemaciclib with giredestrant in ER-positive, HER2-negative early breast cancer; the study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Giredestrant (giredestrant)

Snippet

Sponsor: Fondazione Oncotech | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING